Annals of the New York Academy of Sciences
May 30, 1997
F J Vocci, E D London
6 citations
New technologies utilized for monitoring brain function can be more sensitive in the assessment of desired or undesired pharmacological effects than can clinical examination. Nonetheless, careful case-by-case analysis is required to determine to what extent a change detected with a sensitive imaging modality will have clinical significance. Whereas in some instances the technology may suggest a...
The End of Magic
May 15, 1997
Ariel Glucklich
AbstractWhat is magic? What does magic do? Why do people believe in magic in the face of experience? After living in the Indian city of Banaras and making several trips to tribal areas in Uttar Pradesh, Rajasthan, and Orissa, the author of this chapter discovered a surprising fact: magic is rarely a simple matter of belief. Few magicians and clients in Banaras ever ask themselves why their...
Neuroscience
May 1997
D Kahn, Edward F Pace-Schott, J A Hobson
State-dependent aspects of consciousness are explored with particular attention to waking and dreaming. First, those phenomenological differences between waking and dreaming that have been established through subjective reports are reviewed. These differences are robustly expressed in most aspects of consciousness including perception, attention, memory, emotion, orientation, and thought. Next,...
Human Psychopharmacology: Clinical and Experimental
May 1, 1997
D. Davison, A. C. Parrott
136 citations
Twenty recreational drug users were asked to describe the psychological and physiological effects they experienced under MDMA (3,4-methylenedioxymethamphetamine). The subjects comprised 11 males and nine females, in the age range 18–31 years. Five subjects had taken MDMA once, nine had taken it 2–9 times, while six subjects had taken it +10 times. Each subject completed a modified Profile of...
Drug and Alcohol Dependence
April 14, 1997
A M Cho, Dennis W. Coalson, P A Klock et al.
The purpose of this study was to characterize the reinforcing, subjective and psychomotor effects of nitrous oxide in healthy volunteers with different alcohol histories. Subjects were divided into two groups: light drinkers (n = 9) and moderate drinkers (n = 10). A choice procedure was used in which subjects first sampled placebo and a given concentration of nitrous oxide, and then chose...
Pharmacology, Biochemistry, and Behavior
March 1997
Kinzo Matsumoto, Maho Mizowaki, S Thongpraditchote et al.
The alpha2-adrenoceptor agonist clonidine, as well as 5-HT2 receptor antagonists, reportedly suppress 5-HT2 receptor-mediated head-twitch behavior. We investigated the effect of alpha2-adrenoceptor antagonists on the suppressive action of 5-HT2 receptor antagonists in mice pretreated with the noradrenaline toxin 6-hydroxydopamine (6-OHDA) or the 5-HT synthesis inhibitor p-chlorophenylalanine...
Brain Research
February 28, 1997
Stanley D Glick, Isabelle M Maisonneuve, S M Pearl
38 citations
Ibogaine, a putatively anti-addictive alkaloid, binds to kappa-opioid and NMDA receptors. In the present study we investigated the roles of kappa-opioid and NMDA actions in mediating ibogaine's (40 mg/kg, i.p.) behavioral and neurochemical effects in rats. A combination of a kappa-opioid antagonist (norbinaltorphimine, 10 mg/kg, s.c.) and a NMDA agonist (NMDA, 20 mg/kg, i.p.) partially...
Fortschritte der Neurologie · Psychiatrie
February 1, 1997
Rainer Thomasius, Margit Schmolke, Dana Kraus
Epidemiological research and Substance Abuse Warning Systems point to a sharp increase in the use of "Ecstasy" (MDMA), as well as to structural changes in the drug scene in and outside Europe. For some consumers, "Ecstasy" opens the door to the abuse of other illegal substances. Since the mid-eighties psychiatric complications and consequences of the abuse of MDMA have been reported in at least...
The FASEB Journal
February 1, 1997
Rabi Simantov, M Tauber
89 citations
The widely abused amphetamine analog 3,4‐methylenecdioxymethamphetamine (MDMA, also called “ecstasy”) induces hallucination and psychostimulation, as well as long‐term neuropsychiatric behaviors such as panic and psychosis. In rodents and monkeys, MDMA is cytotoxic to serotonergic neurons, but this is less clear with humans. Herein, MDMA was cytotoxic to human serotonergic JAR cells; it altered...
Psychopharmacology
February 1, 1997
Isabelle M Maisonneuve, G L Mann, C R Deibel et al.
38 citations
There is increasing evidence that the rewarding effect of nicotine is mediated by the mesolimbic dopamine system. The first objective of this study was to examine the dopamine response to repeated i.v. infusions of nicotine. Using in vivo microdialysis in awake and freely moving male Sprague-Dawley rats, we demonstrated that i.v. nicotine infusions (0.16 mg/kg or 0.32 mg/kg per infusion)...